Molecular Mechanisms of Schizophrenia
暂无分享,去创建一个
Jürgen Gallinat | Undine E. Lang | Daniel J. Müller | Imke Puls | J. Gallinat | D. Müller | U. Lang | N. Strutz‐Seebohm | I. Puls | Nathalie Strutz-Seebohm
[1] N. Rajakumar,et al. Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum , 2005, Biological Psychiatry.
[2] Manuel Desco,et al. Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene , 2005, NeuroImage.
[3] P. Ascher,et al. Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.
[4] E. Gershon,et al. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.
[5] Y. Fukumaki,et al. Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia , 2004, BMC psychiatry.
[6] D. Lewis,et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.
[7] P. Falkai,et al. [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts]. , 2006, Der Nervenarzt.
[8] S. Akbarian,et al. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders , 2006, Brain Research Reviews.
[9] P. Levitt,et al. Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia. , 2007, Schizophrenia bulletin.
[10] M. Tohyama,et al. DISC1 localizes to the centrosome by binding to kendrin. , 2004, Biochemical and biophysical research communications.
[11] Robin M. Murray,et al. Environmental risk factors for psychosis , 2005, Dialogues in clinical neuroscience.
[12] Yuhei Nakamura,et al. Functional polymorphism of −141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia , 1998, Psychiatry Research.
[13] Thomas E. Nichols,et al. Impact of complex genetic variation in COMT on human brain function , 2006, Molecular Psychiatry.
[14] Benjamin W. H. Lim,et al. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars , 2007, Proceedings of the National Academy of Sciences.
[15] J. Vázquez-Barquero,et al. Association between the interleukin‐1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment † , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[16] R. Yolken,et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. , 2007, Schizophrenia bulletin.
[17] Daniel R Weinberger,et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. , 2004, Archives of general psychiatry.
[18] David J. Porteous,et al. The Genetics and Biology of Disc1—An Emerging Role in Psychosis and Cognition , 2006, Biological Psychiatry.
[19] Daniel R. Weinberger,et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia , 2007, Human Genetics.
[20] M. Krebs,et al. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants , 2005, Neuroreport.
[21] S. Snyder,et al. Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Collier,et al. Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples , 2006, Biological Psychiatry.
[23] M. Schwarz,et al. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission , 2006, Neurotoxicity Research.
[24] Vicki L. Ellingrod,et al. Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment , 2005, Schizophrenia Research.
[25] S. Akhondzadeh,et al. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial , 2007, Schizophrenia Research.
[26] A. Chakravarti,et al. No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families , 2005, Molecular Psychiatry.
[27] S. Magder,et al. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation , 2004, Steroids.
[28] J. Shields,et al. A polygenic theory of schizophrenia. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. R. Sargolzaee,et al. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[30] T. d'Amato,et al. No major role for the dopamine D2 receptor Ser → Cys311 mutation in schizophrenia , 1994, Psychiatric genetics.
[31] Karin E. Borgmann-Winter,et al. Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.
[32] P. Sham,et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Owen,et al. No evidence for association between polymorphisms in GRM3 and schizophrenia , 2005, BMC psychiatry.
[34] Christoph Schmitz,et al. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia , 2006, Schizophrenia Research.
[35] E. Hirsch,et al. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. , 2007, The Journal of endocrinology.
[36] Teresa Tallerico,et al. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia , 1999, Psychiatry Research.
[37] P. Gorwood,et al. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. , 2001, Schizophrenia Research.
[38] R. Kessler,et al. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. , 1996, Archives of general psychiatry.
[39] D. Javitt,et al. Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis , 2004, Schizophrenia Research.
[40] S. Cichon,et al. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. , 2002, American journal of medical genetics.
[41] M. Munafo,et al. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies , 2005, Molecular Psychiatry.
[42] J. Rain,et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders , 2004, Molecular and Cellular Neuroscience.
[43] P. Sullivan,et al. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.
[44] S. Faraone,et al. No association of G72 and d-amino acid oxidase genes with schizophrenia , 2006, Schizophrenia Research.
[45] M. King,et al. Schizophrenia: a common disease caused by multiple rare alleles , 2007, British Journal of Psychiatry.
[46] Paul J. Harrison. The neuropathology of schizophrenia , 2008 .
[47] Alan S. Brown,et al. Prenatal infection as a risk factor for schizophrenia. , 2006, Schizophrenia bulletin.
[48] S H Snyder,et al. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Malhotra,et al. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. , 2007, Bipolar disorders.
[50] Paul Greengard,et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. , 2002, Archives of general psychiatry.
[51] N. Brandon,et al. DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness , 2004, Annals of medicine.
[52] P. Riederer,et al. Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder , 1998, Journal of Neural Transmission.
[53] C. Crombie,et al. Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia , 2005, Genes, brain, and behavior.
[54] Ann-Christine Ehlis,et al. Impact of Catechol-O-Methyltransferase on Prefrontal Brain Functioning in Schizophrenia Spectrum Disorders , 2007, Neuropsychopharmacology.
[55] N. Brandon,et al. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment , 2004, Molecular Psychiatry.
[56] P. Insel,et al. Multi-tasking RGS proteins in the heart: the next therapeutic target? , 2005, Circulation research.
[57] R. Belmaker,et al. Low GSK-3 activity in frontal cortex of schizophrenic patients , 2001, Schizophrenia Research.
[58] Lin He,et al. Significant Association Between the Genetic Variations in the 5′ End of the N-Methyl-D-Aspartate Receptor Subunit Gene GRIN1 and Schizophrenia , 2006, Biological Psychiatry.
[59] A. Shulgin. 3-Methoxy-4 5-methylenedioxy Amphetamine, a New Psychotomimetic Agent , 1964, Nature.
[60] P. Schofield,et al. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol , 2007, Psychopharmacology.
[61] G. Kirov,et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[62] H. Möller,et al. IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[63] K. Bechter. Die milde Enzephalitishypothese - neue Befunde und Studien , 2004 .
[64] R. Anney,et al. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population , 2005, Schizophrenia Research.
[65] D. Weinberger,et al. Cell biology of the hippocampal formation in schizophrenia , 1999, Biological Psychiatry.
[66] D. Lancet,et al. Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis , 2004, Biological Psychiatry.
[67] J. Hoenicka,et al. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients , 2006, Acta psychiatrica Scandinavica.
[68] Chang-Gyu Hahn,et al. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. , 2006, Human molecular genetics.
[69] Douglas W. Jones,et al. P300 and genetic risk for schizophrenia. , 2003, Archives of general psychiatry.
[70] C. P. Morris,et al. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia , 2005, Schizophrenia Research.
[71] M. Schwarz,et al. Decreased levels of soluble intercellular adhesion Molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients , 2000, Biological Psychiatry.
[72] E. Tan,et al. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[73] D StClair,et al. -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. , 1999, American journal of medical genetics.
[74] Stephan Eliez,et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. , 2007, The American journal of psychiatry.
[75] M. Owen,et al. Is COMT a susceptibility gene for schizophrenia? , 2007, Schizophrenia bulletin.
[76] Laurent Gouya,et al. The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia , 2004, Schizophrenia Research.
[77] O. Guillin,et al. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine. , 2007, International review of neurobiology.
[78] Paul Greengard,et al. DARPP-32 mediates the actions of multiple drugs of abuse , 2005, The AAPS Journal.
[79] M. Owen,et al. Association analysis of AKT1 and schizophrenia in a UK case control sample , 2007, Schizophrenia Research.
[80] R. Conley,et al. Synaptic differences in the patch matrix compartments of subjects with schizophrenia: A postmortem ultrastructural study of the striatum , 2005, Neurobiology of Disease.
[81] S. Kapur,et al. Schizophrenia: more dopamine, more D2 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[82] P. Schlattmann,et al. Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing , 2003, Biological Psychiatry.
[83] L. Heston,et al. Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[84] Jeffrey A Lieberman,et al. Recent advances in the neurobiology of schizophrenia. , 2003, Molecular interventions.
[85] M. Leboyer,et al. Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[86] M. Karayiorgou,et al. The molecular genetics of the 22q11-associated schizophrenia. , 2004, Brain research. Molecular brain research.
[87] Jürgen Gallinat,et al. Genetic Variations of the NR3A Subunit of the NMDA Receptor Modulate Prefrontal Cerebral Activity in Humans , 2007, Journal of Cognitive Neuroscience.
[88] John Stewart,et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.
[89] M. Itokawa,et al. Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.
[90] G. Racagni,et al. Association Study of –1727 A/T, –50 C/T and (CAA)n Repeat GSK-3β Gene Polymorphisms with Schizophrenia , 2004, Neuropsychobiology.
[91] A. Mortimer,et al. Relationship between estrogen and schizophrenia , 2007, Expert review of neurotherapeutics.
[92] K. Någren,et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo , 2004, Molecular Psychiatry.
[93] Takahisa Taguchi,et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. , 2004, Human molecular genetics.
[94] P. DeRosse,et al. Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia , 2007, Biological Psychiatry.
[95] M C O'Donovan,et al. The molecular genetics of schizophrenia: new findings promise new insights , 2004, Molecular Psychiatry.
[96] R. Panizzutti,et al. Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-d-aspartate (NMDA) receptor coagonist d-serine , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[97] Christopher P Austin,et al. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. , 2003, Human molecular genetics.
[98] Mark Millan. Le récepteur dopaminergique D3 : nouvelle cible pour un traitement amélioré de la schizophrénie , 2005 .
[99] Leena Peltonen,et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.
[100] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[101] Hans O Kalkman,et al. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. , 2006, Pharmacology & therapeutics.
[102] P. Iatropoulos,et al. Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM‐IV‐TR schizophrenia: A pilot case‐control association study in an Italian sample , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[103] O. Pietiläinen,et al. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland , 2007, Schizophrenia Research.
[104] M. Karayiorgou,et al. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.
[105] Y. Fukumaki,et al. Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[106] K. Hashimoto,et al. Identification of Multiple Serine Racemase (SRR) mRNA Isoforms and Genetic Analyses of SRR and DAO in Schizophrenia and d-Serine Levels , 2005, Biological Psychiatry.
[107] R. Straub,et al. Expression of DISC 1 binding partners is reduced in schizophrenia and associated with DISC 1 SNPs , 2006 .
[108] A. Tuulio-Henriksson,et al. Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. , 2007, Human molecular genetics.
[109] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[110] J. Duan,et al. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia , 2005, Molecular Psychiatry.
[111] Alan S. Brown,et al. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. , 2006, The American journal of psychiatry.
[112] Chen-Hao Li,et al. Mutation analysis of DARPP-32 as a candidate gene for schizophrenia , 2006, Schizophrenia Research.
[113] Markus M Nöthen,et al. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia , 1999, Schizophrenia Research.
[114] S H Snyder,et al. Novel neurotransmitters and their neuropsychiatric relevance. , 2000, The American journal of psychiatry.
[115] S. Mosolov,et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.
[116] Tyrone D. Cannon,et al. Association of DISC 1 / TRAX Haplotypes With Schizophrenia , Reduced Prefrontal Gray Matter , and Impaired Short-and Long-term Memory , 2005 .
[117] Pablo V Gejman,et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. , 2006, American journal of human genetics.
[118] J. Aldenhoff,et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin , 2007, Molecular Psychiatry.
[119] Stefan Arnborg,et al. Potential genetic variants in schizophrenia: A Bayesian analysis , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[120] R James,et al. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria , 2004, Molecular and Cellular Neuroscience.
[121] Paul J. Harrison,et al. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.
[122] Yue-Cune Chang,et al. Dopamine D3 Receptor Ser9Gly Polymorphism and Risperidone Response , 2005, Journal of clinical psychopharmacology.
[123] Lin He,et al. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. , 2006, Human molecular genetics.
[124] C. Austin,et al. Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development , 2004, Neuroscience.
[125] Y. Fukumaki,et al. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia , 2003, Psychiatric genetics.
[126] B. Hemmings,et al. Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.
[127] S. Cichon,et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. , 2005, The American journal of psychiatry.
[128] A. Meyer-Lindenberg,et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[129] Lin He,et al. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis , 2007, Genetics in Medicine.
[130] H. Yamasue,et al. No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population , 2006, Schizophrenia Research.
[131] S Purcell,et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia , 2005, Molecular Psychiatry.
[132] Christopher A. Ross,et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development , 2005, Nature Cell Biology.
[133] X. Zhang,et al. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology , 2002, Schizophrenia Research.
[134] J. Lieberman,et al. Brain volume in first-episode schizophrenia , 2006, British Journal of Psychiatry.
[135] S. Faraone,et al. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia , 2003, Molecular Psychiatry.
[136] B. Devlin,et al. Novel, Replicated Associations Between Dopamine D3 Receptor Gene Polymorphisms and Schizophrenia in Two Independent Samples , 2006, Biological Psychiatry.
[137] M. Owen,et al. No evidence for association between polymorphisms in GRM3 and schizophrenia , 2005, BMC psychiatry.
[138] T. Arinami,et al. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case–control population , 2004, Molecular Psychiatry.
[139] W. Muir,et al. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[140] R. Panizzutti,et al. Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity* , 2005, Journal of Biological Chemistry.
[141] Tyrone D. Cannon,et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. , 2005, Archives of general psychiatry.
[142] 尾關 祐二. Disrupted-in-Schizophrenia-1 (DISC-1) : mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth , 2004 .
[143] S. Tsai,et al. Family-based association study between G72/G30 genetic polymorphism and schizophrenia , 2006, Neuroreport.
[144] W. Maier,et al. Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families , 2005, Biological Psychiatry.
[145] K. Kanyas,et al. Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: Findings from identity by descent haplotype sharing analysis , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[146] David C Glahn,et al. Spatial working memory as an endophenotype for schizophrenia , 2003, Biological Psychiatry.
[147] M. Ikeda,et al. Association of AKT1 with schizophrenia confirmed in a Japanese population , 2004, Biological Psychiatry.
[148] R. Roberts. Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. , 2006, Schizophrenia bulletin.
[149] Anat Levit,et al. A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia , 2006, Human Genetics.
[150] D. Weinberger,et al. Schizophrenia as a developmental disorder of the cerebral cortex , 1998, Current Opinion in Neurobiology.
[151] A. Bellon. New genes associated with schizophrenia in neurite formation: a review of cell culture experiments , 2007, Molecular Psychiatry.
[152] R. Yolken,et al. Association study of IL10, IL1β, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs16944 at IL1β , 2006, Schizophrenia Research.
[153] M. Tsuang,et al. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder , 2007, Psychiatric genetics.
[154] K. Bechter. [The mild encephalitis-hypothesis--new findings and studies]. , 2004, Psychiatrische Praxis.
[155] Stephan Eliez,et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome , 2005, Nature Neuroscience.
[156] Michael C O'Donovan,et al. Support for RGS4 as a susceptibility gene for schizophrenia , 2004, Biological Psychiatry.
[157] G. He,et al. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population , 2005, Schizophrenia Research.
[158] J. Hallmayer,et al. Getting our AKT together in schizophrenia? , 2004, Nature Genetics.
[159] Toshiyasu Suzuki,et al. Acute treatment with morphine augments the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain. , 2005, European journal of pharmacology.
[160] R. Straub,et al. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. , 2006, The American journal of psychiatry.
[161] Elias Zintzaras,et al. Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis , 2007, Psychiatric genetics.
[162] N. Brandon,et al. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[163] M. Talkowski,et al. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil , 2004, Genes, brain, and behavior.
[164] Daniel C. Javitt,et al. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia , 2005, Biological Psychiatry.
[165] M. Egan,et al. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms , 2007, Molecular Psychiatry.
[166] Chih-Chiang Chiu,et al. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. , 2005, Archives of general psychiatry.
[167] P. Tonali,et al. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain , 2007, European Neuropsychopharmacology.
[168] P. Greengard,et al. Diverse Psychotomimetics Act Through a Common Signaling Pathway , 2003, Science.
[169] R. Tavcar,et al. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. , 2005, Croatian medical journal.
[170] Ivan Nikolov,et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria , 2004, Biological Psychiatry.
[171] Tao Li,et al. The genetics of schizophrenia: glutamate not dopamine? , 2003, European journal of pharmacology.
[172] J. Tiihonen,et al. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis , 2005, Schizophrenia Research.
[173] G. Reynolds,et al. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response , 2005, European Neuropsychopharmacology.
[174] R. Straub,et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.
[175] Richard Coppola,et al. The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia , 2006, Neuropsychopharmacology.
[176] R. Straub,et al. Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy , 2007, Molecular Psychiatry.
[177] B. Kirkpatrick,et al. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex , 2006, The Journal of comparative neurology.
[178] Naoshi Kaneko,et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. , 2005, American journal of human genetics.
[179] H. Beckmann,et al. Gross and Histological Criteria for Developmental Disorders in Brains of Schizophrenics , 1989, Journal of the Royal Society of Medicine.
[180] M. Berk,et al. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder , 2007, Neuroscience Letters.
[181] H. Gurling,et al. Fine Mapping by Genetic Association Implicates the Chromosome 1q23.3 Gene UHMK1, Encoding a Serine/Threonine Protein Kinase, as a Novel Schizophrenia Susceptibility Gene , 2007, Biological Psychiatry.
[182] Zhen Yan,et al. Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.
[183] B. Devlin,et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.
[184] T. Arinami,et al. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.
[185] D. Grayson,et al. DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 Genes , 2007, Molecular Pharmacology.
[186] E. G. Jones,et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.
[187] R. Konno,et al. Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-d-aspartate receptor-mediated synaptic transmission in mutant mice lacking d-amino-acid oxidase , 2001, Neuroscience Letters.
[188] A. Sawa,et al. Disrupted‐in‐Schizophrenia‐1 (DISC1) , 2006, Annals of the New York Academy of Sciences.
[189] V. Arolt,et al. The Influence of Typical and Atypical Neuroleptic Drugs in the Production of Interleukin-2 and Interferon-Gamma in vitro , 2003, Neuropsychobiology.
[190] Lin He,et al. No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population. , 2008, Journal of psychiatric research.
[191] P. Carvey,et al. Dopamine D3 Receptors , 2012 .
[192] H. Shiraishi,et al. Novel variants in the promoter region of the CREB gene in schizophrenic patients , 1999, Journal of Human Genetics.
[193] M. Matsushita,et al. A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia , 2007, Biological Psychiatry.
[194] Birgit Funke,et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. , 2004, American journal of human genetics.
[195] P. Visscher,et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.
[196] N. Craddock,et al. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. , 2005, Schizophrenia bulletin.
[197] W. Maier,et al. Fortschritte in der neurobiologischen Erforschung der Schizophrenie , 2006, Der Nervenarzt.
[198] M. Harte,et al. The neuronal pathology of schizophrenia: molecules and mechanisms. , 2007, Biochemical Society transactions.
[199] 神谷 篤. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development , 2006 .
[200] Daniel R Weinberger,et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. , 2006, Human molecular genetics.
[201] R. Kahn,et al. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia , 2007, European Neuropsychopharmacology.
[202] L. Almasy,et al. A Novel Missense Mutation in the Transmembrane Domain of Neuregulin 1 is Associated with Schizophrenia , 2006, Biological Psychiatry.
[203] Heather C Whalley,et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms , 2006, Nature Neuroscience.
[204] M. Farquhar,et al. The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.